Overlapping area represents amount of risk that can be diversified away by holding Biovail Corp. Common Stoc and Hospira Inc in the same portfolio (assuming nothing else is changed)
Valeant Pharmaceuticals International, Inc. raised bidding price from $6.50 to $7.50 per share in cash relevant to its earlier proposed price for the acquisition of ISTA Pharmaceuticals.
The Shareholders Foundation announces that an investor in NYSE: HSP shares filed a lawsuit against certain directors of Hospira, Inc. over alleged breaches of fiduciary duties for their alleged failure to manage the company properly.
BlackRock is one of the most influential financial institutions in the world. It manages assets worth ~$ 3.5 trillion. I discussed BlackRock's best performing buys from the September quarter in a previous article.
Abbott Laboratories and Hospira Inc. (HSP) won a US appeals court ruling upholding a trial court finding the companies didn't mislead workers about retirement benefit levels to induce them to leave Abbott for its Hospira spinoff.
2012-02-03
Medicines Co. Settles with APP
2012-01-24
Biosimilars: The Next New Thing
2012-01-13
Hospira Upped to Neutral
2012-01-05
Updating Transaction...
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
Filter Tops
Biovail Corp. Common Stoc and 
Hospira Inc
Hospira Inc
2.19% 
